Actively Recruiting

Phase Not Applicable
Age: 15Years - 24Years
All Genders
NCT06156306

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

Led by Chinese University of Hong Kong · Updated on 2025-07-10

50

Participants Needed

1

Research Sites

106 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Insomnia in adolescents and youth is a long-standing public health concern due to its high prevalence and association with various physical and mental health problems. Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. CBT for insomnia (CBT-I) has been shown to be effective in improving sleep complaints and short-term improvement in mood while previous systematic reviews of interventional studies have demonstrated the effectiveness of acceptance and commitment therapy (ACT) interventions in treating insomnia, both as a primary condition and with other physical and/or mental health comorbidities. This study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth.

CONDITIONS

Official Title

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

Who Can Participate

Age: 15Years - 24Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Chinese youth aged 15-24 years old
  • Presence of insomnia problems defined by insomnia severity index (ISI) cut-off of 9
  • Presence of anxiety features defined by General Anxiety Disorder-7 (GAD-7) cut-off of 10
  • Ability to listen, speak, and read Chinese and Cantonese
  • Written informed consent given by youth and parent's consent if under 18 years old; individual assent for subjects under 18
  • Possession of a smartphone
Not Eligible

You will not qualify if you...

  • Clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual disability
  • Diagnosed sleep disorder (e.g., delayed sleep phase, narcolepsy) affecting sleep quality as determined by Diagnostic Interview for Sleep Patterns and Disorders (DISP)
  • Clinically significant suicidality with plan or attempt as assessed by The Structured Clinical Interview (SCID)
  • Currently receiving psychological or pharmacological treatment for insomnia or anxiety disorder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Psychiatry, the Chinese University of Hong Kong

Shatin, New Territories, Hong Kong

Actively Recruiting

Loading map...

Research Team

R

Rachel Ngan Yin Chan, PhD

CONTACT

J

Julia Wai Han Sun, M.S.Sc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here